-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LTI-01 in Empyema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LTI-01 in Empyema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LTI-01 in Empyema Drug Details: LTI-01 is under development for the treatment...
-
Product Insights
NewNet Present Value Model: Aileron Therapeutics Inc’s Sulanemadlin
Empower your strategies with our Net Present Value Model: Aileron Therapeutics Inc's Sulanemadlin report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LTI-03 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LTI-03 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LTI-03 in Idiopathic Pulmonary Fibrosis Drug Details: LTI-03 is under development...
-
Product Insights
NewPleural Effusion – Drugs In Development, 2024
Empower your strategies with our Pleural Effusion – Drugs In Development, 2024 report and make more profitable business decisions. Pleural Effusion also known as fluid in lungs is a condition where accumulation of fluid in pleural space of lungs observed. Underlying disease conditions of the lungs like pneumonia, emphysema, TB, etc, and other conditions like CKD, heart failure, and pancreatitis can also cause pleural effusion, and sometimes the etiology is unknown. It is usually classified as transudates and exudates. Normal pleural...
-
Product Insights
NewPleural Disease – Drugs In Development, 2024
Empower your strategies with our Pleural Disease – Drugs In Development, 2024 report and make more profitable business decisions. Pleural disorders encompass a spectrum of conditions affecting the protective tissue surrounding the lungs and lining the chest cavity. Within this category, three distinct types emerge—namely pleurisy, pleural effusion, and pneumothorax—each with diverse etiologies. Characterized by inflammation of the pleura, pleurisy stands as a primary manifestation. Conversely, pleural effusion and pneumothorax result from factors such as infection, medical conditions, or chest trauma,...
-
Product Insights
NewChronic Kidney Disease (Chronic Renal Failure) – Drugs In Development, 2024
Empower your strategies with our Chronic Kidney Disease (Chronic Renal Failure) – Drugs In Development, 2024 report and make more profitable business decisions. Chronic kidney disease is the slow loss of kidney function over time. Signs and symptoms of kidney disease include nausea, vomiting, loss of appetite, fatigue and weakness, sleep problems, hiccups, and swelling of feet and ankles. The predisposing factors include age, diabetes, high blood pressure, heart disease, smoking, obesity, and high cholesterol. The Chronic Kidney Disease (Chronic Renal...
-
Product Insights
NewInterstitial Lung Fibrosis – Drugs In Development, 2024
Empower your strategies with our Interstitial Lung Fibrosis – Drugs In Development, 2024 report and make more profitable business decisions. Interstitial Lung Fibrosis or interstitial lung disease (ILD) is a group of diseases that cause scarring of the lungs (fibrosis) or lung parenchyma. If untreated it can lead to respiratory failure and death. Symptoms start with inflammation and can result in bronchiolitis, vasculitis, and alveolitis. Exposure to hazardous chemicals or materials like asbestos, hypersensitivity, drug-induced, underlying autoimmune conditions, family history, smoking,...
-
Company Profile
Aileron Therapeutics Inc – Company Profile
Aileron Therapeutics Inc (Aileron Therapeutics) is a biopharmaceutical company. The company develops medicines to make chemotherapy safer and thereby more effective to save more patients’ lives. Its products include ALRN-6924 MDM2 and MDMX dual inhibitor a chemoprotective agent that treats patients with p53-mutated cancers. It also provides radioprotection, anti-cancer research and discovery research. The company partners with research organizations to provide its products. Aileron Therapeutics is headquartered in Boston, Massachusetts, the US.
Add to Basket -
Product Insights
Aileron Capital – Phoenix Aileron Apartment – Arizona
Equip yourself with the essential tools needed to make informed and profitable decisions with our Aileron Capital - Phoenix Aileron Apartment - Arizona report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Company Profile
Arafura Rare Earths Ltd – Company Profile
Arafura Rare Earths Ltd (Arafura) is a rare earth metals mining and exploration company. It is involved in exploration and development of various mineral sources including rare earths and phosphate. The company had major project such as Nolan project. It also owns other exploration projects including Aileron-Reynolds project and Bonya JV. Rare earth products find application in advanced ceramics and high strength permanent magnets that allow e-mobility and renewable energy applications. The company’s rare earth products are used in magnetic,...
Add to Basket